{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"75"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"23"}],"units":"Participants"}],"description":"Maximum tolerated dose of azacitidine when used in combination with temozolomide","groups":[{"description":"Subjects will receive azacitidine in combination with temozolomide\n\nAzacitidine: Azacitidine will be delivered sub-cutaneously for 5 days\n\nTemozolomide: Temozolomide will be given starting on day 8 for 5 days at a dose of 200 mg/m2 po qd x 5 days","id":"OG000","title":"Treatment"}],"paramType":"NUMBER","reportingStatus":"POSTED","timeFrame":"Up to 26 weeks for each dosing cohort","title":"Maximum Tolerated Dose of Azacitidine","type":"PRIMARY","unitOfMeasure":"mg/m^2"}